Radiodynamic therapy + AMINOLEVULINIC ACID HYDROCHLORIDE for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Oct 2022: Trial registered, NCT05590689
  2. 9 Nov 2022: Trial started, NCT05590689

The trials

NCT05590689: Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor

State
Under way
Phase
Phase 1 and Phase 2
People
34 planned
Started
9 Nov 2022
Primary completion
Jan 2028
Arms
Radiodynamic therapy (RDT)
Results
None posted
  1. 21 Oct 2022: Trial registered
  2. 9 Nov 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.